NCT05171894View on ClinicalTrials.gov

A Study to Evaluate Efficacy and Safety of Light Dose in Subjects with PWB Treated with Hemoporfin PDT

PHASE2RecruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

September 21, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

April 30, 2026

Conditions
Port-wine BirthmarksPort-Wine StainNevus Flammeus
Interventions
DRUG

Hemopfin+Green Light

All qualified subjects randomized to Hemoporfin PDT treatment to receive up to 3 cycles of treatment.

DEVICE

Vehicle+Green Light

All qualified subjects randomized to vehicle PDT treatment to receive up to 3 cycles of treatment.

Trial Locations (6)

18015

NOT_YET_RECRUITING

St. Luke's University Health Network, Bethlehem

21030

RECRUITING

Maryland Dermatology, Laser, Skin & Vein Institute, Hunt Valley

33173

RECRUITING

Miami Dermatology and Laser Institute, Miami

33180

RECRUITING

Skin and Cancer Associates (SCA) and the Center for Cosmetic Enhancement (CCE), Aventura

92121

RECRUITING

Dermatology Cosmetic Associates of La Jolla, Inc. d/b/a West Dermatology Research Center, San Diego

92697

NOT_YET_RECRUITING

UCI Health Beckman Laser Institute & Medical Clinic, Irvine

All Listed Sponsors
lead

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

INDUSTRY